STIFEL FINANCIAL CORP

Position in MNKD — Mannkind Corp

CIK 720672 ST. LOUIS, MO

Position in MNKD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$431,077

+$257,186 QoQ

Shares Held

101,192

+42.6% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#89

of 254 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $537,727,692 across 104 Biotechnology names. MNKD ranks #68 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BHVN	Biohaven Ltd.	9,941,165	$147,924,534
2	VRTX	Vertex Pharmaceuticals Inc / Ma	162,151	$80,545,262
3	MANE	Veradermics, Inc	294,117	$36,158,743
4	JAZZ	Jazz Pharmaceuticals plc	139,491	$33,613,146
5	REGN	Regeneron Pharmaceuticals, Inc.	46,378	$28,918,535
6	OMER	Omeros Corp	1,836,925	$17,469,155
7	NTLA	Intellia Therapeutics, Inc.	1,014,387	$17,163,427
8	IONS	Ionis Pharmaceuticals Inc	202,983	$16,094,521

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$431,077	101,192	+42.6%	Shares	Defined	2026-08-12
2026-03-31	$173,891	70,976	+29.7%	Shares	Defined	2026-05-12
2025-12-31	$310,375	54,740	+25.5%	Shares	Defined	2026-02-13
2025-09-30	$234,265	43,625	-40.3%	Shares	Defined	2025-11-12
2022-06-30	$278,640	73,134	-35.9%	Shares	Defined	2022-08-15
2022-03-31	$419,862	114,093	+5.3%	Shares	Defined	2022-05-13
2021-12-31	$473,585	108,372	+16.8%	Shares	Defined	2022-02-14
2021-09-30	$403,492	92,757	-5.2%	Shares	Defined	2021-11-15
2021-06-30	$533,020	97,802	-2.3%	Shares	Defined	2021-08-13
2021-03-31	$392,439	100,112	+158.6%	Shares	Defined	2021-05-14
2020-12-31	$121,165	38,711	—	Shares	Defined	2021-02-12
No filing history on record for this holder in this stock.